SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical ...

ACADIA Pharmaceuticals (NASDAQ:ACAD) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to highlight ...

Acadia Realty Trust’s fourth-quarter earnings remained relatively stagnant compared to previous times, but that hasn’t changed the company’s focus on expanding its street retail across the U.S. Acadia ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...

Acadia Pharmaceuticals has shown significant financial improvement, reporting a profit of $82.7m in 2024, compared to a loss of $(107m) in 2023. The company's revenue growth is driven by NUPLAZID and ...

Good day, ladies and gentlemen, and welcome to the ACADIA Pharmaceuticals Conference Call. My name is Shannon, and I will be your coordinator for today. I would now like to turn the presentation over ...

In the preceding three months, 13 analysts have released ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD), presenting a wide array of perspectives from bullish to bearish. The table below provides a ...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Catherine Owen Adams has succeeded Steve Davis as Chief Executive Officer (CEO) and joined the Acadia Board ...

A little-known Westchester-based real estate investor is continuing its Manhattan shopping spree into the new year with its latest acquisition, a $25 million purchase in SoHo, records show. Acadia ...